These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26915860)
1. Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients. Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Kim KH; Park GC; Kim BS; Park IJ; Lim SB; Kim JC; Yoo MW; Byeon JS; Jung HY; Lee GH; Myung SJ; Choe J; Choi JY; Park HW; Lee SG Transplant Proc; 2016; 48(1):145-51. PubMed ID: 26915860 [TBL] [Abstract][Full Text] [Related]
2. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations. Nasser-Ghodsi N; Mara K; Watt KD Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906 [TBL] [Abstract][Full Text] [Related]
3. Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers. Hamashima C; Narisawa R; Ogoshi K; Kato T; Fujita K BMC Cancer; 2017 Nov; 17(1):740. PubMed ID: 29121881 [TBL] [Abstract][Full Text] [Related]
4. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Park HW; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Yoon SY; Park CS; Park YH; Lee HJ; Lee SG Transplant Proc; 2012 Apr; 44(3):802-5. PubMed ID: 22483500 [TBL] [Abstract][Full Text] [Related]
5. De Novo Gastric Cancer After Liver Transplantation. Gong CS; Yoo MW; Kim BS; Hwang S; Kim KH; Yook JH; Kim BS; Lee SG Ann Transplant; 2016 Jun; 21():386-91. PubMed ID: 27334929 [TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis. Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287 [TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study. Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224 [TBL] [Abstract][Full Text] [Related]
9. Posttransplant malignancies in liver transplant recipients. Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170 [TBL] [Abstract][Full Text] [Related]
11. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501 [TBL] [Abstract][Full Text] [Related]
12. Survival after the diagnosis of de novo malignancy in liver transplant recipients. Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D; Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809 [TBL] [Abstract][Full Text] [Related]
13. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival. Sharma P; Goodrich NP; Schaubel DE; Smith AR; Merion RM Liver Transpl; 2017 Sep; 23(9):1143-1152. PubMed ID: 28688150 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of endoscopic submucosal dissection in gastric neoplastic lesions at a single institution in South Korea. Jang JS; Choi SR; Qureshi W; Kim MC; Kim SJ; Jeung JS; Han SY; Noh MH; Lee JH; Lee SW; Baek YH; Kim SH; Choi PJ Scand J Gastroenterol; 2009; 44(11):1315-22. PubMed ID: 19891582 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of gastric cancer surveillance in renal transplant recipients. Lee IS; Kim TH; Kim YH; Yook JH; Kim BS; Han DJ World J Surg; 2012 Aug; 36(8):1806-10. PubMed ID: 22526049 [TBL] [Abstract][Full Text] [Related]
16. Changing pattern of biliary complications in an evolving liver transplant unit. Rammohan A; Govil S; Vargese J; Kota V; Reddy MS; Rela M Liver Transpl; 2017 Apr; 23(4):478-486. PubMed ID: 28152569 [TBL] [Abstract][Full Text] [Related]
17. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590 [TBL] [Abstract][Full Text] [Related]
18. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Jun JK; Choi KS; Lee HY; Suh M; Park B; Song SH; Jung KW; Lee CW; Choi IJ; Park EC; Lee D Gastroenterology; 2017 May; 152(6):1319-1328.e7. PubMed ID: 28147224 [TBL] [Abstract][Full Text] [Related]
20. Is a stricter colonoscopy screening protocol necessary in liver transplant recipients? Comparison with an average-risk population. Lee HS; Yoo DJ; Park HW; Yang DH; Myung SJ; Yang SK; Lee SG; Byeon JS Dis Colon Rectum; 2014 Aug; 57(8):976-82. PubMed ID: 25003292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]